Medibank shares fall despite big 2030 transformation plans

Let's see what Medibank is planning for a big earnings boost.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Medibank Private plans to accelerate its transformation into a leading health company by expanding its role beyond insurance into the broader healthcare system.
  • The company aims to increase earnings from its health segment to $200 million by FY 2030 and grow its policyholder market share while focusing on wellbeing, primary care, community care, and insurance.
  • CEO David Koczkar emphasises transforming healthcare delivery from treatment to prevention and enhancing digital and personalised care to sustain health outcomes.

Medibank Private Ltd (ASX: MPL) shares are in the spotlight on Wednesday.

In morning trade, the health insurance giant's shares are down almost 1% to $4.86.

meal preparation of healthy food in a family kitchen

Image source: Getty Images

Medibank shares drop despite transformation plans

This morning, the private health insurer unveiled an ambitious plan to accelerate its transformation into a leading Australian health company.

Ahead of a "health immersion" event for investors today, it outlined how it plans to expand its role beyond health insurance and into the broader healthcare system.

Ambitious FY 2030 targets

Medibank has set out a series of long-term aspirations aimed at strengthening its business and driving shareholder value.

The company now aims to lift earnings from its Medibank Health segment to at least $200 million by FY 2030. This is up from $76.7 million in FY 2025.

It also aims to grow its policyholder market share each year in a disciplined way, targeting at least 26.8% by FY 2030.

A third target for 2030 is to double its health and wellbeing engagement, reaching around 10 million Australians by the end of the decade.

Commenting on the targets, Medibank's chief executive officer, David Koczkar, said:

Australia's healthcare system is one of the best in the world, but it is under pressure and urgently needs meaningful transformation to ensure we can keep up with the increasing needs in the community. It's time for the health system to shift from treatment to prevention, from hospital to community, from analogue to digital and from generic to personalised care. Investing in technology and connecting health is critical to accelerate this momentum. These four big shifts are essential to drive the health transition and to sustain the world leading health outcomes we all experience today.

Medibank has been driving the health transition. Over the last decade, we have invested more than $300 million to grow as a health company. We will remain focused on delivering for our customers and long-term value for our shareholders by accelerating our growth strategy, and today we have set out some very clear milestones alongside a new ambition.

Growth in four key segments

To achieve its goals, Medibank plans to focus on four major health areas. They are as follows:

  • Wellbeing – Expanding its Live Better rewards program, workplace health initiatives, and financial wellbeing offerings.
  • Primary care – Growing its general practice network and virtual healthcare services under its Amplar Health brand.
  • Community and acute care – Providing hospital-level care at home and expanding short-stay and rehabilitation services.
  • Health insurance – Continuing to improve value and choice for its 4.2 million policyholders.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

ASX share investor sitting with a laptop on a desk, pondering something.
Share Fallers

CSL shares crash to a 9-year low. Is it time to sell off my shares?

What's next for the beaten-down ASX biotech stock?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

This ASX biotech hit a 90% success rate. Can it unlock commercial growth?

Orthocell is already seeing growing adoption, with more than 300 surgeons across over 220 hospitals in Australia using Remplir.

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Healthcare Shares

This ASX biotech is pushing for a Nasdaq listing. Could it reignite investor interest?

The NASDAQ has a reputation for providing a platform for some of the world's most innovative companies.

Read more »

Smiling health care workers in a medical setting.
Healthcare Shares

3 ASX healthcare shares to buy amid sector rout: experts

Healthcare shares have tumbled 36% over the past year amid multiple headwinds for the sector.

Read more »

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

This ASX biotech has just announced a major US deal

This company's heart disease technology is gaining traction.

Read more »

Devastated woman sits near smartphone on home kitchen floor troubled with loneliness.
Healthcare Shares

Which beaten down ASX healthcare stock is a better buy right now: Pro Medicus vs Cochlear shares

Which do experts prefer?

Read more »

Health professional working on his laptop.
Healthcare Shares

Already up 42% this year, Morgans says this ASX healthcare stock can continue to rocket

This broker sees big upside for this healthcare stock.

Read more »